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Abstract
The purpose of the present work was to progress in our understanding of the pathophysiolo-
gy of L-2-hydroxyglutaric aciduria, due to a defect in L-2-hydroxyglutarate dehydrogenase,
by creating and studying a mouse model of this disease. L-2-hydroxyglutarate dehydroge-
nase-deficient mice (l2hgdh-/-) accumulated L-2-hydroxyglutarate in tissues, most particu-
larly in brain and testis, where the concentration reached 3.5 μmol/g. Male mice showed
a 30% higher excretion of L-2-hydroxyglutarate compared to female mice, supporting that
this dicarboxylic acid is partially made in males by lactate dehydrogenase C, a poorly specif-
ic form of this enzyme exclusively expressed in testes. Involvement of mitochondrial malate
dehydrogenase in the formation of L-2-hydroxyglutarate was supported by the commensu-
rate decrease in the formation of this dicarboxylic acid when down-regulating this enzyme
in mouse l2hgdh-/- embryonic fibroblasts. The concentration of lysine and arginine was
markedly increased in the brain of l2hgdh-/- adult mice. Saccharopine was depleted and glu-
tamine was decreased by 40%. Lysine-α-ketoglutarate reductase, which converts lysine
to saccharopine, was inhibited by L-2-hydroxyglutarate with a Ki of 0.8 mM. As low but
significant activities of the bifunctional enzyme lysine-α-ketoglutarate reductase/saccharo-
pine dehydrogenase were found in brain, these findings suggest that the classical lysine
degradation pathway also operates in brain and is inhibited by the high concentrations of L-
2-hydroxyglutarate found in l2hgdh-/- mice. Pathological analysis of the brain showed signifi-
cant spongiosis. The vacuolar lesions mostly affected oligodendrocytes and myelin sheats,
as in other dicarboxylic acidurias, suggesting that the pathophysiology of this model of
leukodystrophy may involve irreversible pumping of a dicarboxylate in oligodendrocytes.
Neurobehavioral testing indicated that the mice mostly suffered from a deficit in learning ca-
pacity. In conclusion, the findings support the concept that L-2-hydroxyglutaric aciduria is a
disorder of metabolite repair. The accumulation of L-2-hydroxyglutarate exerts toxic effects
through various means including enzyme inhibition and glial cell swelling.
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INTRODUCTION
L-2-hydroxyglutaric aciduria is an autosomal recessive neurometabolic disorder characterized
by the accumulation of L-2-hydroxyglutarate [1, 2, 3, 4] and caused by a deficiency in L-2-
hydroxyglutarate dehydrogenase [5, 6, 7]. This non-classical metabolite, which does not belong
to any conventional metabolic pathway in eukaryotes, appears to be formed in most tissues as
the result of a side activity of L-malate dehydrogenase, principally its mitochondrial form.
This enzyme, which is abundant in tissues, catalyses the reduction of oxaloacetate to L-2-
hydroxyglutarate with a catalytic efficiency that is about 107 times lower than that with which
it catalyses the reduction of oxoloacetate to L-malate [8]. Another potential source of L-2-
hydroxyglutarate is lactate dehydrogenase C (also called lactate dehydrogenase X), a form of
lactate dehydrogenase that is exclusively expressed in testes, and which acts not only on pyru-
vate, as do the lactate dehydrogenases encoded by the LDHA and LDHB gene, but also on
other α-ketoacids including α-ketoglutarate, thus producing, at least in vitro, L-2-hydroxyglu-
tarate (reviewed by [9]). There is no known role for L-2-hydroxyglutarate and its concentration
is normally maintained at a very low value in tissues thanks to L-2-hydroxyglutarate dehydro-
genase, an FAD-linked, mitochondrial enzyme [5, 7, 10]. This observation led to the idea that
L-2-hydroxyglutarate dehydrogenase serves a metabolite repair role, by destroying a useless
metabolite, formed because of the lack of absolute specificity of mitochondrial L-malate dehy-
drogenase. This and other examples of enzymes playing a metabolite repair role have recently
been reviewed [11, 12].
Little is presently known on the cause of the toxicity of L-2-hydroxyglutarate. Its structural
resemblance to L-glutamate and α-ketoglutarate, two major metabolites, makes it likely that
the pathophysiology of the disease involves inhibition of enzymes acting normally on gluta-
mate or α-ketoglutarate, or even abnormal utilization of L-2-hydroxyglutarate by such en-
zymes. Testing such hypothesis requires knowledge on the biochemical perturbations induced
by the accumulation of L-2-hydroxyglutarate.
Here, we created a mouse model of L-2-hydroxyglutaric aciduria to progress in our under-
standing of the pathophysiology of this disease, and most particularly to identify the potential
biochemical and pathophysiological consequences of L-2-hydroxyglutarate accumulation.
MATERIALS and METHODS
Animals and ethics statement
All mice were raised under standard husbandry conditions and were housed in colony cages
with a 12h light/dark cycle. They had free access to water and food, unless otherwise specified.
The experiments were performed with the approval of the Ethics Committee on Animal Exper-
iments of the Catholic University of Louvain—department of health sciences (permit number:
2013/UCL/MD/015). Animals were euthanized with CO2 immediately before removing the tis-
sues (biochemical analysis) or deeply anesthetized with pentobarbital (histological and ultra-
structural analysis) to minimize suffering.
Generation of the knockout mice
Mouse embryonic stem cells (cell lineE14Tg2A.4, strain 129/Ola) containing an insertional
mutation in the l2hgdh gene [13] were obtained fromMMRRC (Mutant Mouse Regional Re-
source Centers funded by NIH). The gene-trap vector used (pGT1x) contains a splice-acceptor
sequence upstream of a reporter gene, β-geo (a fusion of β-galactosidase and neomycin phos-
photransferase II). The insertional mutation occurred in the third intron. Thus the mutation
resulted in the production of a fusion transcript encoding the first 137 aminoacid residues of
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L-2-hydroxyglutarate dehydrogenase followed by β-geo. Ten to 15 embryonic stem cells were
injected into the blastocoele of C57BL/6 blastocysts. Forty injected embryos were incubated in
KSOMmedium [14] at 37°C for at least 3 hours before being transferred into oviducts of CD1
pseudopregnant females. Ten chimeric males were obtained. To test the capacity of embryonic
stem cells to contribute to the germline, the male chimeras were mated with C57BL/6 females.
Germline transmission of the embryonic stem cells genotype was indicated by the production
of agouti offspring and confirmed by genotyping by PCR-analysis of tail DNA. The presence of
the wild-type (l2hgdh+/+) and mutated alleles (l2hgdh-/-) was detected in specific PCR-amplifi-
cations using a common forward primer (Fw-8: 5’-TTTCTGAGTTCGAGGTCAGCCTG-3’;
see Fig. 1) and two downstream reverse ones. These were either in intron 3 of the l2hgdh gene
(Rev-In3: 5’-CAGAATTCCATGAAGTGGTAC-3’) or in the inserted DNA (Rev-TV: 5’-
GGACTCCCTGGCCTCCAG −3’). The length of the two amplification products was approxi-
mately 300 bp. All mice described herein had a mixed genetic background (~ 50% C57BL/6
and ~ 50% 129 Ola). All studied l2hgdh+/+ and l2hgdh-/- mice were generated by crossing
heterozygous mice.
Amino acid analysis
Mice starved for 24 h were euthanized as described above, blood was collected, brain and testes
were rapidly removed and frozen in liquid nitrogen. Frozen samples were homogenized with
two vol. of 15% sulfosalicylic acid. Heparinized plasma was mixed with one vol. of 10% sulfosa-
licylic acid. After centrifugation (16000 x g; 15 min at 4°C), the amino acids of plasma and of
brain and testes homogenates were separated and quantified using a Biochrom 30 amino acids
analyzer. For the assay of cystine, frozen brain (0.2 g) was homogenized with two volumes
(0.4 ml) of 5.2 mM N-ethylmaleimide. Following homogenization, the homogenate was sup-
plemented with 0.12 ml of 15% sulfosalicylic acid and clarified by centrifugation (16000 x g;
Fig 1. Generation of the murine l2hgdh-/- model by insertion of a gene trapping cassette.We show the genomic structure of the l2hgdh gene in wild-
type and knock-out mice, which spans 10 exons (black boxes). In the disrupted allele, the gene trapping cassette [containing engrailed intron1 (En2 int1);
Lox71 and LoxP Cre recombination sites (green and blue arrows); FRT flippase recombination sites (red arrows); β-geo cassette (orange box); splicing
acceptor (SA) and polyadenylation (PA) sequences; a portion of pGTX1 vector (pUC backbone)] has been randomly inserted in intron 3, which leads to the
production of an inactive protein comprising the first 137 residues of L-2-hydroxyglutarate dehydrogenase fused to the β-geo cassette. The latter confers
resistance to neomycin and interrupts downstream transcription due to the addition of a polyadenylation signal. The precise site of insertion of the gene-
trapping cassette is shown, as well as the location of the primers (Fw-8; Rev-In3; Rev-TV) used for diagnostic amplification of the wild-type and
mutated alleles.
doi:10.1371/journal.pone.0119540.g001
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15 min at 4°C). Cystine content was measured by LC/MS/MS using an isotopic dilution meth-
od [15]. Pipecolate was determined as described in [16].
L-2-hydroxyglutarate assay
For the measurement of relatively high concentrations of L-2-hydroxyglutarate (as in tissues
and urine of l2hgdh-/- mice), we used a radiochemical assay that was based on the competition
exerted by unlabeled L-2-hydroxyglutarate on the use of radiolabelled L-2-hydroxyglutarate by
partially purified L-2-hydroxyglutarate dehydrogenase [5, 17]. Tissues were directly homoge-
nized in 2 vol. of 10% (v/v) HClO4. After centrifugation (16 000 x g for 10 min at 4°C), the su-
pernatant was neutralized with 3M KHCO3. Where indicated, (D+L)-2-hydroxyglutarate was
assayed in heated tissue extracts by GC/MS. The samples were treated with hydroxylamine hy-
drochloride in the presence of pentadecanoic acid as an internal standard, and extracted with
ethyl acetate followed by diethyl ether. After evaporation of the combined extracts under a
stream of nitrogen, derivatization was achieved with N,O-bis(trimethylsilyl)trifluoroacetamide:
trimethylchlorosilane (BSTFA:TMCS; 99:1). Analysis was performed by GC/MS using a Hew-
lett-Packard 6890 series GC system equipped with 30 m x 0.25-mm fused silica capillary col-
umn CP-SIL 8 CB from Varian, with helium as carrier gas. Detection was performed with a
Hewlett-Packard 5973 mass-selective detector under electron impact fragmentation and with
the scan and selective ion monitoring modes for acquisition. To identify and quantitate 2-
hydroxyglutarate, we compared its retention time, mass spectra and detector response to those
of the commercial compound.
siRNA transfection of MEF primary cell cultures
Mouse embryonic fibroblasts (MEF) isolated from l2hgdh+/+ and l2hgdh-/- mice embryos were
maintained and transfected with siRNAs as described [18]. Control siRNA or mitochondrial
malate dehydrogenase siRNA [both from Dharmacon ON-TARGETplus SMARTpool from
Thermo Scientific (Epsom, UK)] was added at a final concentration of 50 nM using Lipofecta-
mine 2000 (Invitrogen) as the transfection reagent. After 48 h, protein was extracted from cells.
The cells were washed with 1 ml phosphate buffered saline (PBS) and harvested in 100 μl of
20 mMHepes (pH 7.1) containing 5 μg/ml antipain as described [7]. Cell media (1 ml) were
used to determine the concentration of 2-hydroxyglutarate by gas chromatography analysis.
The activity of mitochondrial malate dehydrogenase was determined in cell extracts [8].
Western blot analysis
Equal amounts (20 μg) of cell extracts were analyzed by SDS-PAGE. Proteins were transferred
to a Hybond-C Extra membrane (GE Healthcare, Roosendaal, The Netherlands). Next, the
membrane was incubated for 1 h at room temperature with 5% skimmed milk in Tris-buffered
saline followed by an overnight incubation at 4°C with monoclonal anti-mitochondrial malate
dehydrogenase antibody (Human Protein Atlas HPA019714, 1:500) in the same buffer. The
western blot was further performed according to the manufacturer’s protocol.
Partial purification and assay of lysine -α-ketoglutarate reductase
Mouse liver or brain was homogenized with 4 volumes of a buffer containing 25 mMHepes,
pH 7.1, 25 mM KCl, 2 μg/ml leupeptin and antipain. The homogenate was centrifuged at
15 000 x g for 15 min at 4°C and 1 ml of the supernatant was applied on a Blue Trisacryl col-
umn (1 ml bed volume) equilibrated in 20 mMHepes, pH 7.1. The column was washed with
1 ml of the equilibration buffer and protein was eluted with a stepwise NaCl gradient (0.1, 0.2,
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0.5, 1.0, 1.5 and 2.0 M; 1 ml/step) in the same buffer. The enzyme activity was assayed spectro-
photometrically at 30°C in the presence of 25 mMHepes, pH 8.0, 0.15 mM NADPH, 1 mM
dithiothreitol, 5 mM α-ketoglutarate and 10 mM lysine. Saccharopine dehydrogenase was as-
sayed in the presence of the same buffer, 0.5 mMNAD+, and 0.5 mM saccharopine.
RNA isolation and Q-PCR analysis
Total RNA was extracted from tissues as previously described [18]. RNA concentrations were
determined by measuring the absorbance at 260 nm. To determine specific mRNA levels,
cDNA synthesis and quantitative real-time PCR were performed as described previously [18]
using RevertAid H minus reverse transcriptase (Thermo Scientific) and SYBER Green fluores-
cent dye (Bio-Rad), respectively [19]. The sequence of primers used for amplification can be
obtained upon request.
Histological and ultrastructural analysis
Brain histological analysis was performed in mice of various ages, but most of the data pre-
sented here derives from analyses performed on l2hgdh-/- and l2hgdh+/+ 5 to 7 month old litter-
mates (3 males and 4 females from each genotype). The mice were deeply anesthetized with
pentobarbital and trans-cardially perfused with phosphate buffered saline followed by whole-
body perfusion-fixation with 10% neutral-buffered formalin through the left ventricle under a
height of 120 cm, after right atrium excision for outlet, as described [20]. The brain was quickly
dissected. A transverse median slice of the brain of male mice was immediately immersed in
0.5% glutaraldehyde for ultrastructural analysis. The rest of the brain and the whole brain of fe-
male mice were immersed in formalin overnight. A transverse median slice of female brain was
then put in O. C. T. medium (Sakura, Alphen aan den Rijn, The Netherlands) and frozen in liq-
uid nitrogen-cooled isopentane. The other slices were embedded in paraffin. The spinal cord of
the female mice was similarly dissected, fixed and embedded in paraffin.
For light microscopy, histological sections were stained with hematoxylin and eosin, alcian
blue, or luxol fast blue. Frozen sections were stained with oil red O or Sudan black. Immuno-
histochemical analysis of a neuron-specific nuclear protein (with monoclonal mouse anti-
NeuN IgG1 antibody, clone A60; Millipore, Bedford, MA; used at 5 μg/ml) and of oligodendro-
cyte transcription factor 2 (with antigen affinity-purified polyclonal goat IgG anti-human Olig
2; R&D Systems, Abingdon, UK; used at 0.6 μg/ml) was performed using the ultraView Univer-
sal diaminobenzidine detection kit on a Ventana Benchmark XT module (Roche, Basel, Swit-
zerland). Immunohistochemical analysis of Ki67 (monoclonal mouse IgG1K, clone B56; BD
Pharmingen, Erembodegem, Belgium; used at 5 μg/ml) was performed after antigen retrieval
by boiling deparaffinized sections for 75 min. Cleaved caspase-3 (polyclonal rabbit antibodies,
from Cell Signaling—Millipore; 1:100) was immunodetected without antigen retrieval. After
incubation overnight at 4°C with the primary antibody, sections were rinsed, incubated with
peroxidase-conjugated dextran molecules carrying anti-mouse or rabbit IgG antibodies (Envi-
sion, DakoCytomation, Glostrup, Denmark), followed by incubation with H2O2 and diamino-
benzidine. Mouse small bowel was used as positive control for the latter two antigens.
For ultrastructural analysis, tissue pieces were post-fixed in 1% OsO4 in 0.1 M cacodylate
buffer for 1 h, rinsed in veronal buffer and stained overnight “en bloc” in 1% neutral uranyl ac-
etate in the dark, all at 4°C. After extensive washing in veronal buffer, blocks were dehydrated
in graded ethanol and embedded in Spurr. Areas for ultrathin sections were selected on tolui-
dine blue stained semi-thin sections. Ultrathin (70 nm nominal) sections were obtained with a
Reichert ultramicrotome (Reichert, Austria), collected on rhodanium 400 mesh grids and con-
trasted with 3% uranyl acetate followed by lead citrate for 10 min each. Grids were washed
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with water, dried and examined in a FEI CM12 electron microscope (Philips, Eindhoven, The
Netherlands) operating at 80 kV.
Neurobehavioral testing
Modified SHIRPA test. This test was used as a simple first-line observational phenotypic
test [21]. Briefly, the mice are run through a battery of tests consisting in the observation of a
variety of spontaneous (viewing jar) and provoked behaviors (arena) such as body position,
rearing, locomotor activity, gait, reflexes, and anxiety. A score sheet was used to record the ob-
servation. A description and list of the scoring parameters can be found at http://empress.har.
mrc.ac.uk/.
Open-Field Test. This test was used to assess nonforced ambulation in a new environment
as mice can move freely without any influence of the examiner. Briefly, mice were placed twice
at one-month interval in a square arena (60 x 60 cm) and video-tracked (Ethovision 6.1, Nol-
dus; Wageningen, The Netherlands) for 20 min. The total distance covered by the animals was
measured [22].
Grip Strength Test. Combined forelimb and hindlimb muscle strength was measured by
gently lowering a mouse on the top of a grid connected to a sensor (Panlab-Bioseb, Vitrolles
France) so that both front paws and hind paws could grip the grid. The mice were then pulled
back steadily down the complete length of the grid until the grip was released. This test con-
sisted of three trials performed with 15 min intervals. Results are means of the two highest val-
ues of force recorded, related to body weight [22].
Rotarod test. Mice were tested for their ability to keep their balance and coordination on a
rotating rod (Bioseb, Vitrolles, France). The time (latency) taken to fall off the rod rotating
under continuous acceleration (e.g. from 4 to 40 rpm) was measured. Mice performed 3 trials
per day during 5 days. Animals staying for 300 s were taken from the rotarod and recorded as
300 s. Results are presented as the mean of the 3 trials [23].
Y maze test. This test was used to assess working memory. The Y maze was made of 3
identical opaque arms (35 cm length x 5 cm width x 10 cm height) placed at 120° from each
other. Mice were placed into a start arm and video-tracked with Ethovision 6.1 for 5 min. Total
number of arm entries and arm alternation were recorded. Alternations (taken as an indicator
of short-term memory) are determined as successive entries into three different arms.
Water maze test. The Morris water maze test was used to assess spatial learning and mem-
ory. Water maze was made of a round pool with a diameter of 113 cm, virtually divided into
four quadrants (North, South, West and East) and filled with water (26°C). Several visual cues
were placed around the pool. Mice were tested on 5 consecutive days with 5 consecutive trials
per day. During the trials of the first 4 days, the animals were placed in the pool facing the side-
wall and allowed to swim freely to the platform. The latter was placed at the center of the
North-West quadrant of the pool and was visible on the training day and submerged 1 cm
under the water surface on the 3 following days. The initial position in which the animal was
left in the pool varied among trials. If the animal did not find the platform during a 60 s period,
it was gently guided to it, allowed to remain on the platform for 5 s, and removed from the
pool before being placed in the next initial starting position in the pool. On the 5th day, the ani-
mals were submitted to a probe test, which consisted in allowing the mice to swim freely for
60 s in the pool from which the escape platform had been removed. During all these tests, the
mice were video-tracked with Ethovision 6.1. The escape latency time (i.e. the time to reach the
platform), the swimming speed, the time spent in each quadrant and the distance from the
platform location were registered [24].
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Metabolic analyses. Mice basal activity (rearing and locomotor activity), food and water
intake were measured in individual ‘Physiocages’ (Panlab-Bioseb, Vitrolles, France) during
48 h after 24 h of habituation [25].
Wire test. Mice were suspended by their forelimbs to a 1.5-mm-thick, 60-cm-long metallic
wire 45 cm above soft ground. The time of latency until the mouse completely released its
grasp and fell down was recorded. Three trials were performed per session, with a 30-s recovery
period between trials. The maximum time per trial was set to 180 s. For each mouse, the latency
times of the three trials were averaged [26].
RESULTS
Generation of l2hgdh-/- mice
ES cells with a genetrap inactivation of the l2hgdh gene were obtained from the gene trap con-
sortium. Sequencing of the chimeric cDNA indicated that the vector had been inserted in in-
tron 3 (Fig. 1) leading to a fusion protein comprising the first 137 residues of L-2-
hydroxyglutarate dehydrogenase fused to a β-geo cassette. Downstream transcription of the
l2hgdh gene is interrupted by a polyadenylation signal present in the genetrap vector. The pre-
cise site of insertion was determined by PCR amplification and sequencing (see Fig. 1). This al-
lowed the design of primers for the specific amplification of DNA for the mutated and the
non-mutated alleles of the gene (see Materials and Methods).
Male chimeras obtained as described in the Materials and Methods were mated with
C57BL/6 mice to found a colony. The crossing of heterozygous mice yielded proportions of
l2hgdh+/+, l2hgdh+/-, and l2hgdh-/- (66:125:64) close to the expected 25:50:25 proportion, indi-
cating no embryonic lethality of the l2hgdh-/- mice.
qPCR experiments on liver mRNA with primers in exon 4 and exon 5 of the l2hgdh tran-
script indicated that the mRNA was nearly absent (<5% of the normal value) in l2hgdh-/- mice
and amounted to 50% of the normal value in heterozygous mice (not shown). The finding of
low but detectable levels of transcripts in l2hgdh-/- mice indicates that the polyadenylation sig-
nal present in the inactivation cassette is leaky. The presence of potential normal transcripts,
due to splicing of exon 3 with the normal exon 4 was tested by quantitative RT-PCR amplifica-
tion of the cDNA with primers hybridizing with these two exons. Starting from brain cDNA
from l2hgdh-/- mice, we observed an amplification product of the same size as with cDNA ob-
tained from l2hgdh+/+ mice. qPCR indicated, however, that its quantity in l2hgdh-/- mice
amounted to 0.67 ± 0.15% (mean ± SEM for n = 8) of the amount found in l2hgdh+/+ mice.
These findings suggest that in l2hgdh-/- mice, a small amount of readthrough transcript is syn-
thesized and spliced in a similar manner as the wild type RNA. However, the resulting L-2-
hydroxyglutarate dehydrogenase activity should represent no more than 1% of the normal
activity.
There was no obvious difference in lethality between l2hgdh+/+ and l2hgdh-/- mice for the
animals kept in the specific-pathogen-free animal house, but there was a tendency to a higher
lethality (5/23 as compared to 0/24) when the mice were taken out of this environment (e.g. for
testing).
Since male ldhx-/- mice are hypofertile [27], we tested the fertility of male l2hgdh-/- mice, but
did not find evidence for decreased fertility. Indeed, crossing knockout male and female mice
gave litters of similar size to the ones resulting from the crossing of wild-type mice.
L-2-hydroxyglutarate: levels in tissues and origin
Analysis of L-2-hydroxyglutarate in tissues of l2hgdh-/- mice (Fig. 2A) using our bioassay
indicated that this compound was particularly abundant in brain and in testis, where its
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concentration amounted to 3.5 μmol/g, with lower values in other tissues. L-2-hydroxygluta-
rate was undetectable in tissues from normal mice (< 100 μMwith the bioassay), to the excep-
tion of testis, where its concentration amounted to 0.35 μmol/g in control mice (not shown).
L-2-hydroxyglutarate levels were also determined in 24 h urine collections. As shown in
Fig. 2B, urinary excretion of L-2-hydroxyglutarate amounted to 6.5 ± 0.6 and 4.9 ± 0.3 mol/mol
creatinine in male and female l2hgdh-/- mice, respectively, indicating that male mice produced
about 30%more L-2-hydroxyglutarate than female mice, presumably due to the activity of the
testis-specific enzyme lactate dehydrogenase C on α-ketoglutarate (see Discussion).
Previous work has shown that the L-2-hydroxyglutarate-producing enzyme co-elutes with
mitochondrial L-malate dehydrogenase in liver [8]. To verify that this enzyme is the main one
Fig 2. L-2-hydroxyglutarate concentration in different tissues (A) and its urinary excretion (B) in
l2hgdh+/+ and l2hgdh-/- mice. Tissues of l2hgdh-/- male mice (n = 4) were analyzed in (A). Values of urinary
excretion for male and female mice (n = 3) are shown in (B). Results are means ± SEM. * p< 0.05 by
unpaired t test.
doi:10.1371/journal.pone.0119540.g002
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involved in L-2-hydroxyglutarate production in tissues other than testis, we investigated the ef-
fect of mitochondrial L-malate dehydrogenase suppression on the accumulation of L-2-hydro-
xyglutarate in l2hgdh-/- MEF (mouse embryonic fibroblasts) cells (Fig. 3). Treatment of these
cells with siRNAs specific for mitochondrial L-malate dehydrogenase caused an almost com-
plete disappearance of the mitochondrial L-malate dehydrogenase mRNA and a partial disap-
pearance of immunoreactive mitochondrial L-malate dehydrogenase (Fig. 3A) and enzymatic
activity (Fig. 3B). Consistent with a partial decrease in mitochondrial L-malate dehydrogenase
activity, we found that (D+L)-2-hydroxyglutarate concentration in the cell culture media was
reduced by about 2-fold in l2hgdh-/- MEF cells (Fig. 3C). The (D+L)-2-hydroxyglutarate con-
centration was not affected by knockdown of mitochondrial L-malate dehydrogenase in
l2hgdh+/+ cells, indicating that mitochondrial L-malate dehydrogenase specifically affected the
production of the L-isomer of 2-hydroxyglutarate. Taken together these findings indicate that
the main two enzymes involved in L-2-hydroxyglutarate formation are mitochondrial L-malate
dehydrogenase and lactate dehydrogenase C (see Fig. 4).
Modification of amino acids in brain
Analysis of amino acids and other amines in brain showed a marked increase in the concentra-
tion of lysine ( 3.4-fold), arginine (2.3-fold), and free ethanolamine (1.7 fold). Saccharopine
was depleted, and glutamine and glutamate were decreased by 45 and 22%, respectively (Fig. 5
and Table 1). Saccharopine, cystine and pipecolate are difficult to separate with the conven-
tional technique used for the determination of amino acids. However, close inspection of the
chromatograms of samples enriched with standards indicated that the peak that we attributed
to saccharopine was precisely eluted together with the saccharopine standard, whereas the
pipecolate standard was eluted 0.1 min later. Specific assays for cystine and pipecolate by
LC/MS/MS indicated that these amino acids did not account for the saccharopine peak, and
that their concentration (cystine: 0.51 ± 0.03 and 0.63 ± 0.29 nmol/g and pipecolate: 2.0 ± 1.0
and 1.5 ± 0.7 nmol/g, respectively for l2hgdh+/+ and l2hgdh-/- mice; mean values ± SEM for n =
3) was not increased in the l2hgdh-/- mice compared to the l2hgdh+/+. There were no statistical-
ly significant changes in the concentration of amino acids in the plasma and in testis (Table 1).
Presence of lysine-α-ketoglutarate reductase in brain and its inhibition
by L-2-hydroxyglutarate
Lysine degradation is usually assumed to take place via the formation of saccharopine in liver
but via L-pipecolate in brain [28] (Fig. 4). The finding that in brain lysine accumulation was ac-
companied by a suppression of saccharopine (Fig. 5A; Table 1) suggested that lysine degrada-
tion could proceed in brain via saccharopine and that this pathway was inhibited by L-2-
hydroxyglutarate.
We first checked for the presence of lysine-α-ketoglutarate reductase in brain by chromato-
graphing extracts of mouse brain and liver on Blue Trisacryl columns, on which lysine-α-keto-
glutarate reductase is well retained and eluted only with high salt concentrations (Fig. 6). We
found indeed that brain, whether from control or l2hgdh-/- mice, contained an activity that was
about 150-fold lower than the activity present in mouse liver. This activity co-eluted with sac-
charopine dehydrogenase both in the case of the liver and brain enzyme (Fig. 6A and 6B). This
is expected since the two enzymes are known to form a bifunctional protein [28].
We next tested whether lysine-α-ketoglutarate reductase (purified from mouse or rat liver)
would be inhibited by L-2-hydroxyglutarate and found indeed that this enzyme was inhibited
by this compound (Fig. 6C), whereas almost no inhibition was observed with D-2-hydroxyglu-
tarate. The inhibition by L-2-hydroxyglutarate was competitive with respect to α-ketoglutarate,
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with a Ki of 0.7 mM. Lysine-α-ketoglutarate reductase forms a bifunctional enzyme with
NAD-dependent saccharopine dehydrogenase. This activity, which, expectedly, coeluted with
lysine-α-ketoglutarate reductase, was not inhibited by L-2-hydroxyglutarate (not shown).
Pathological analysis
Pathological analysis on the brain of l2hgdh-/- mice was performed on 5–7 month-old mice.
The brain of the l2hgdh-/- mice consistently showed an extensive spongiotic appearance that
was predominant in the caudate putamen (Fig. 7C), the basal ganglia and the brainstem, in
particular in the pencils of Wilson and the white matter fascicles, where the myelin bundles ap-
peared distorted (Fig. 7D and 7F). The deep layers of the cerebral cortex and the corpus callo-
sum (Fig. 8A-D) also showed a spongiotic pattern as well as the cerebellar nuclei (Fig. 8I-L).
The hippocampus was less severely affected, with vacuoles in its white matter, mostly under
the corpus callosum (Fig. 8E-H). In contrast, the spinal cord did not show a spongiotic pattern
(Fig. 8M-P). At high magnification, the cytoplasm of oligodendrocytes, and possibly of astro-
cytes, appeared vacuolated (Fig. 7D and 7F). Most vacuoles were present in oligodendrocytes
as assessed by immunostaining of NeuN for neurons and Olig2 for oligodendrocytes (Fig. 7I
and J). The nucleus of some neurons was also indented by vacuoles but it was not possible to lo-
calize these vacuoles confidently inside the neurons since they could also be inside the
Fig 3. L-2-hydroxyglutarate formation in l2hgdh-/- cells is decreased if mitochondrial malate
dehydrogenase (mMDH) is knocked down.MEF cells derived from l2hgdh+/+ and l2hgdh-/- 14.5 day-
embryos were treated with control (scrambled) or mMDH-specific siRNAs for 48 h. (A) mMDH
immunoreactivity was determined in lysates of cells treated or not with siRNA. (B) mMDH activity in cell
lysates was determined by separating this enzyme from cytoplasmic MDH by cation exchange
chromatography. (C) (D+L)-2-hydroxyglutarate concentration was determined in the medium by GC-MS.
doi:10.1371/journal.pone.0119540.g003
Fig 4. Formation and breakdown of L-2-hydroxyglutarate and interference of this compound with
lysine metabolism. The scheme shows how L-2-hydroxyglutarate is formed and degraded. It also shows the
initial steps of the major lysine catabolic pathway (via saccharopine) present in mammalian tissues and of the
minor pathway (via L-pipecolate) present in brain and the inhibition exerted by L-2-hydroxyglutarate. 1.
Lysine-α-ketoglutarate reductase; 2. Saccharopine dehydrogenase; 3. α-Aminoadipate semialdehyde
dehydrogenase; 4. α-Aminoadipate transaminase; 5. Imine reductase; 6. L-Pipecolate oxidase.
doi:10.1371/journal.pone.0119540.g004
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Fig 5. Decreased (A) or increased (B) concentrations of brain amino acids of l2hgdh-/- mice compared
to l2hgdh+/+mice. Brains from 24 h fasted mice aged 4–6 months were analyzed. ‘Serine x 10’ and
‘Saccharopine x 100’ indicate that the actual concentrations in brain is 10-fold or 100-fold lower, respectively,
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cytoplasm of the satellite oligodendrocytes (Fig. 7I). Oil red O and Sudan black did not stain
the vacuoles in frozen sections, indicating they did not contain lipids, and no mucin accumula-
tion was disclosed by alcian blue staining of paraffin sections (not shown).
At the ultrastructural level, many empty-looking dilated cell processes that contained al-
tered, often dilated, organelles (“vacuoles inside vacuoles” pattern) were observed in the glia of
l2hgdh-/- mice (Fig. 7M and N). It was not possible to determine to which cell type these cyto-
plasmic processes belonged. The myelin sheath of axons often appeared disrupted, sometimes
with spaces dissociating the myelin layers (Fig. 7N). Immunostaining of Ki67 did not indicate
any cell proliferation and cleaved caspase-3 was not immunodetected, suggesting that apopto-
sis did not occur in the brain of l2hgdh-/- mice (not shown). There was no evidence for in-
creased occurrence of tumors in brain or other organs in l2hgdh-/- mice.
Locomotor and cognitive function
Locomotor activity in a familiar environment and consumption of food and drink were not sig-
nificantly different between l2hgdh-/- and l2hgdh+/+ mice. While muscle strength of fore- and
hind-limbs were not significantly different, l2hgdh-/- mice appeared to be more susceptible to
fatigue, as indicated by the wire test (Table 2). No impairment of coordination was observed
during the accelerating rotarod test (data not shown).
Interestingly, in comparison to l2hgdh+/+ mice, rearing activity was increased by about 2.6
fold in l2hgdh-/- mice (Table 2). The distance moved by the l2hgdh-/- mice when placed in a
novel environment (open field test) was increased by about 175% compared to l2hgdh+/+ mice
(Table 2). Furthermore, in contrast to l2hgdh-/- mice, l2hgdh+/+ mice progressively diminished
their activity during the testing period (20 min), reflecting some habituation to their environ-
ment. Moreover, when the test was repeated after one month, l2hgdh+/+ mice presented a loco-
motor activity that was diminished by half, whereas the activity of l2hgdh-/- mice was
diminished by only 20%, again showing a decreased habituation to a known environment for
l2hgdh-/- mice (Table 2).
Learning ability of l2hgdh+/+ and l2hgdh-/- mice was evaluated with the Y maze test and the
Morris water maze test. In the Y maze test (Table 2), l2hgdh-/- mice displayed a significantly
lower percentage of alternations compared with l2hgdh+/+ mice, indicating an impairment of
working memory. In the Morris water maze test (Fig. 9), the escape latency did not differ sig-
nificantly between the l2hgdh+/+ and l2hgdh-/- mice on the training day (when the platform was
visible). The swimming speed was also similar, suggesting the absence of any major locomotor
defect. It decreased progressively for both groups during the test trials performed during the
following three days and became then significantly lower in the l2hgdh+/+ mice compared to
the l2hgdh-/- mice (Fig. 9A), indicating that the l2hgdh-/- mice had a reduced learning capacity.
This conclusion was supported by the finding that during the probe test performed on the fifth
day (the platform was then removed), the l2hgdh+/+ mice spent more time than the l2hgdh-/-
mice in the quadrant where the platform had been present (Fig. 9B), and swam, on average,
closer to the platform than did the l2hgdh-/- mice during this test (Fig. 9C).
Finally, the sensitivity of l2hgdh-/- mice to convulsants was assessed by intraperitoneal injec-
tion of a subconvulsive dose of pentylenetetrazole. In contrast to l2hgdh+/+ mice, this dose was
sufficient to induce major convulsive seizures in l2hgdh-/- mice (Fig. 10).
compared to the values that are shown in the Y axis. Results are the means ± SEM for n = 10 (l2hgdh+/+) or
n = 6 (l2hgdh-/-) mice. *: 0.0003< alpha< 0.0016; **: alpha< 0.0003; ns: non significant. The analysis was
performed using the Student t-test with a Bonferroni correction for multiple testing (see also Table 1).
doi:10.1371/journal.pone.0119540.g005
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DISCUSSION
Source of L-2-hydroxyglutarate
Previous work based on enzyme purification indicated that the main enzyme able to produce
L-2-hydroxyglutarate in liver is mitochondrial L-malate dehydrogenase [8], a widespread en-
zyme present in all tissues. This conclusion was consistent with data obtained with fibroblasts
Table 1. Amino acids in brain, testis and plasma of l2hgdh+/+ and l2hgdh−/− mice.
Brain Testis Plasma
l2hgdh+/+ l2hgdh−/− l2hgdh+/+ l2hgdh−/− l2hgdh+/+ l2hgdh−/−
Samples (n) 10 6 4 4 3 3
Alanine 667 ± 118 535 ± 71 1244 ± 116 1102 ± 171 293 ± 76 268 ± 18
Saccharopine 16 ± 3 < 1.0 *
Aspartate 2868 ± 356 2105 ± 212 2027 ± 167 2275 ± 419 9 ± 3 10 ± 1
Glutamate 8693 ± 593 6825 ± 334* 3102 ± 552 3084 ± 262 33 ± 12 46 ± 12
Phenylalanine 53 ± 8 59 ± 7 68 ± 12 77 ± 11 92 ± 17 94 ± 28
Glycine 1216 ± 128 954 ± 192 2540 ± 79 2719 ± 212 181 ± 24 210 ± 10
Histidine 50 ± 8 60 ± 9 63 ± 11 71 ± 10 55 ± 7 67 ± 17
Isoleucine 58 ± 13 53 ± 6 74 ± 9 84 ± 5 149 ± 34 146 ± 50
Leucine 107 ± 21 114 ± 10 160 ± 43 163 ± 5 310 ± 123 315 ± 181
Lysine 187 ± 25 638 ± 93* 228 ± 33 260 ± 31 329 ± 152 395 ± 177
Methionine 25 ± 6 26 ± 7 34 ± 7 40 ± 7 49 ± 9 45 ± 3
Asparagine 94 ± 11 81 ± 10 143 ± 15 165 ± 33 61 ± 9 55 ± 14
Glutamine 5923 ± 713 3205 ± 433 1282 ± 66 1424 ± 281 695 ± 79 443 ± 125
Arginine 87 ± 5 200 ± 27* 66 ± 12 60 ± 6 97 ± 20 114 ± 18
Serine 811 ± 52 550 ± 124* 278 ± 12 275 ± 74 107 ± 17 107 ± 25
Threonine 309 ± 30 379 ± 43 280 ± 50 315 ± 67 153 ± 17 180 ± 63
Valine 215 ± 62 138 ± 11 470 ± 67 469 ± 36 363 ± 202 367 ± 226
Tryptophan nd nd 18 ± 1 26 ± 4 36 ± 16 47 ± 31
Tyrosine 41 ± 12 45 ± 12 61 ± 16 63 ± 8 75 ± 29 86 ± 44
P-Serine 86 ± 15 82 ± 17 154 ± 23 148 ± 17 11 ± 4 13 ± 4
Taurine 8874 ± 524 8763 ± 553 2508 ± 185 2528 ± 138 618 ± 194 705 ± 47
P-Ethanolamine 1714 ± 78 1659 ± 95 4810 ± 196 4910 ± 99 11 ± 4 16 ± 3
α-Aminoadipate 230 ± 50 136 ± 93 171 ± 41 175 ± 15 14 ± 2 16 ± 10
Cystathionine 26 ± 8 32 ± 7 nd nd nd nd
β-alanine 76 ± 10 77 ± 10 nd nd nd nd
GABA 3069 ± 243 2769 ± 97 33 ± 3 31 ± 4 nd nd
Ammonia 845 ± 240 937 ± 145 278 ± 13 276 ± 44 190 ± 57 257 ± 39
Carnosine 135 ± 39 109 ± 9 nd nd nd nd
Ethanolamine 100 ± 20 174 ± 14* 158 ± 33 176 ± 50 nd nd
α-Aminobutyrate 29 ± 7 18 ± 5 13 ± 2 15 ± 6 29 ± 10 18 ± 2
Ornithine 11 ± 2 10 ± 1 17 ± 5 13 ± 2 67 ± 28 112 ± 62
Citrulline 9 ± 1 14 ± 4 16 ± 6 12 ± 1 49 ± 18 54 ± 30
Same experimental procedure as in Fig. 5.
Values are means ± SEM for the number of samples indicated that are shown in nmol/g (brain, testis) or nmol/ml (plasma).
*Signiﬁcantly different values (alpha < 0.0016) are indicated with an asterisk.
The analysis was performed with the Student t-test with a Bonferroni correction for multiple testing (32 parameters).
doi:10.1371/journal.pone.0119540.t001
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Fig 6. Presence of the bifunctional enzyme lysine-α-ketoglutarate reductase/saccharopine dehydrogenase in brain (A, B) and inhibition of lysine-
α-ketoglutarate reductase by L-2-hydroxyglutarate (C). (A) and (B) show the elution profile of lysine-α-ketoglutarate reductase (LαKGR) and
saccharopine dehydrogenase (SD) from Blue Trisacryl columns on which a mouse liver (A) or a mouse brain (B) extract have been applied. (C) Partially
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of patients with L-2-hydroxyglutaric aciduria, indicating that L-2-hydroxyglutarate is formed
from the mitochondrial pool of α-ketoglutarate rather than from the cytosolic pool [29]. We
now confirm these conclusions by showing that the formation of L-2-hydroxyglutarate in MEF
cells is dependent on the activity of mitochondrial L-malate dehydrogenase. The majority of
the L-2-hydroxyglutarate formed results therefore from a metabolic error, i.e. the formation of
a non-classical metabolite catalyzed by the side reaction of an enzyme that has a different
physiological function.
The finding that male mice excrete significantly more L-2-hydroxyglutarate than female
mice and that L-2-hydroxyglutarate is particularly elevated in testis indicate that in this tissue,
L-2-hydroxyglutarate may be largely formed by LDHC (also known as LDHX). LDHC, which
is exclusively expressed in sperm cells, is known to be rather non specific, since it is able to re-
duce not only pyruvate, but also α-ketoglutarate and other α-keto acids to the corresponding
L-2-hydroxyacids [9, 30]. The role, if any, of L-2-hydroxyglutarate and other L-2-hydroxy
acids that are also presumably formed by LDHC is not known. Yet the importance of LDHC is
underlined by the fact that its absence leads to male sterility or hypofertility in mice [27]. No
evidence for hypofertility was, however, observed when male and female l2hgdh-/- mice were
crossed (not shown), suggesting that L-2-hydroxyglutarate metabolism does not play a critical
role in testis physiology. Since LDHC is also highly expressed in human testis (as indicated by
the BioGPS database), it is likely that L-2-hydroxyglutarate accumulates to high levels also in
human testis. Whether this has any clinical consequence is unknown.
Mechanism of lysine accumulation
Lysine metabolism classically proceeds in mammals either via the saccharopine pathway or
the L-pipecolate pathway, which converge to form aminoadipate semialdehyde (Fig. 4) [28].
The first pathway, which is present in liver, kidneys and, with lower activities, in most other
tissues, involves reduction of lysine and α-ketoglutarate to saccharopine followed by oxidation
of the latter to L-glutamate and α-aminoadipate semialdehyde. These two activities are cata-
lysed by one single bifunctional enzyme, whose deficiency results in hyperlysinemia [31].
α-Aminoadipate semialdehyde is then oxidized by aminoadipate semialdehyde dehydrogenase
(ALDH7A1) to aminoadipate, which is then further metabolized via α-ketoadipate.
The second pathway, which is thought to be the main one in brain, is initiated by the con-
version of lysine to its α-keto derivative by an unidentified enzyme, possibly an oxidase or a
transaminase. Piperideine-2-carboxylate, which results from the spontaneous cyclisation of the
product of the first reaction is then reduced to L-pipecolate, by imine reductase, an enzyme
that is essentially present in brain, and which was recently identified as the product of the
CRYM (μ-crystallin) gene [32]. Pipecolate is then oxidized to piperideine-6-carboxylate
(Fig. 4).
The concentration of lysine is higher in the plasma and in the CSF of patients with L-2-
hydroxyglutaric aciduria [33]. We reproduced this observation for brain in mice with L-2-
hydroxyglutaric aciduria. The increase is particularly impressive, since it reached about 4-fold.
A non significant trend to an increase is also found in blood.
purified lysine-α-ketoglutarate reductase frommouse liver was assayed at 30°C in the presence of 25 mM Hepes, pH 8.0, 0.15 mMNADPH, 1 mM
dithiothreitol, 10 mM lysine (Lys) and 2, 5 or 10 mM α-ketoglutarate (α-KG) as indicated and increasing concentrations of L-2-hydroxyglutarate. The effect of
L-2-hydroxyglutarate was also tested in the presence of 25 mM lysine and 2 mM α-ketoglutarate and that of D-2-hydroxyglutarate with 10 mM lysine and
2 mM α-ketoglutarate.
doi:10.1371/journal.pone.0119540.g006
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Fig 7. Pathological analysis of l2hgdh-/- mice. The figure compares the histological and ultrastructural
appearance of the brain of l2hgdh+/+ (left panels: A, B, E, G, H, K, L) and l2hgdh-/- mice (right panels: C, D, F,
I, J, M, N). Hematoxylin and eosin staining shows low-magnification of the lateral part of the brain (A, C) at the
level of the lateral ventricle (LV), the caudate putamen (striatum; CPu) and the anterior commissure, anterior
part (aca). Higher magnification of pencils of Wilson are shown in panels B and D. Notice the satellite
oligodendrocyte at B (arrow). Luxol fast blue staining of myelin is shown in E and F, highlighting the
predominant presence of vacuoles in the pencils of Wilson of the striatum of the l2hgdh-/- mouse. Panels G-J
are microphotographs from the junction between cortex and white matter in the vicinity of corpus callosum.
Immunostaining of NeuN (G and I) shows that most vacuoles in the l2hgdh-/- mice are at distance from the
nucleus of neurons (notice the abundance of vacuoles in the lower part of panel I, devoid of neurons)
although a few vacuoles indent the nucleus of some neurons (arrowheads). However, the nucleus of satellite
oligodendrocytes is also present in close contact to the vacuole indenting the nucleus of some neurons
Mouse Model of L-2-Hydroxyglutaric Aciduria
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The finding that lysine-α-ketoglutarate reductase is inhibited by L-2-hydroxyglutarate, a
structural analog of one of the two substrates of this enzyme, with a Ki that is lower than the
concentration of L-2-hydroxyglutarate in brain suggests that there is a metabolic block at the
level of this enzyme. This is also supported by the finding that the concentration of saccharo-
pine is decreased in the brain of mice with L-2-hydroxyglutaric aciduria. Lysine-α-ketogluta-
rate reductase is known to be active in mouse brain at early stages of development [34]. Its
presence in the adult brain is disputed, since it was not found by Sauer et al. [35], but well in
the present study, in agreement with previous mRNA expression data [36]. Taken together
with the metabolite modifications found in L-2-hydroxyglutaric aciduria, the low activity of
the bifunctional enzyme (about 0.7% of the activity found in liver) suggests that lysine metabo-
lism, which is slow in brain, proceeds at least partly via saccharopine.
Intriguingly, no significant difference in plasma or testis lysine concentration were observed
between control and l2hgdh-/- mice. In plasma, this is likely due to the fact that the L-2-hydro-
xyglutarate concentration is much less elevated in liver, the main organ responsible for lysine
degradation, than it is in brain. In testis, this is possibly due to the absence of lysine-α-ketoglu-
tarate reductase in this tissue, but this point has not been explored.
Kamoun et al. [33] proposed that the hyperlysinemia found in L-2-hydroxyglutaric aciduria
is due to a depletion in the concentration of α-ketoglutarate, as they noted that the concentra-
tion of lysine is decreased in metabolic diseases where the concentration of α-ketoglutarate is
increased. As we see here, an additional mechanism is the direct effect of L-2-hydroxyglutarate
on lysine-α-ketoglutarate reductase.
The effect of L-2-hydroxyglutarate accumulation on lysine metabolism is interesting from
the biochemical standpoint, but does probably not contribute to the neurological symptoms,
since defects in lysine metabolism due to lysine-α-ketoglutarate reductase deficiency do not ap-
pear to cause pathological symptoms [37].
We have no simple explanation for the change in the concentration of other amino acids in
brain. The lack of difference in amino acid concentrations in testis of wild-type and knockout
mice, despite high levels of L-2-hydroxyglutarate in this tissue in the L-2-hydroxyglutarate de-
hydrogenase-deficient mice, is possibly due to higher exchange rates of the amino acid pools
between testis and the circulation, compared to brain.
Origin of the brain lesions
In humans, L-2-hydroxyglutaric aciduria usually presents as a slowly progressing neurodegen-
erative process manifested by mental retardation, spasticity and ataxia, and seizures appearing
during infancy, and classically induces pathognomonic MRI changes including signal abnor-
malities of the subcortical cerebral white matter, putamen, caudate nucleus, globus pallidus
and dentate nucleus [38, 39, 40]. However, phenotypic variations have been reported such as a
rapidly progressing disease in a neonate [2] or on the other hand a poorly symptomatic disease
diagnosed in a 40 year-old male [41]. The latter case did not show dentate nucleus MRI
(arrows), preventing to identify clearly which cell type actually contains the peri-neuronal vacuole. In contrast,
immunostaining of Olig2 (H and J) clearly shows that most vacuoles are in close contact to the nucleus of
oligodendrocytes in the l2hgdh-/- mouse brain. Notice the small size of the nucleus of oligodendrocytes
compared to the nucleus of neurons. Panels K-N are Transmission Electron Microscopy photographs of
striatum tissue. Ultrastructural analysis (K-N) shows many empty-looking cell processes (asterisks in panels
M and N), containing dilated cytoplasmic organelles, in the glia of l2hgdh-/- mice. The myelin sheath of many
axons appears focally altered or disrupted (arrows at M and N), sometimes at the vicinity of empty-looking
spaces. C, capillary lumen. The length of the scale bar is indicated in each panel.
doi:10.1371/journal.pone.0119540.g007
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Fig 8. Representative microphotographs of different sites of the brain and spinal cord of l2hgdh-/-
compared to l2hgdh+/+mice. A-D, transverse sections through the corpus callosum (cc); E-H, transverse
sections through the hippocampus (dg, dentate gyrus); I-L, sections through the cerebellum and cerebellar
nuclei (cn); M-P, transverse sections through the spinal cord (ah, anterior horn). Left panels (A, B, E, F, I, J,
M, N) are representative of l2hgdh+/+mice and right panels (C, D, G, H, K, L, O, P) of l2hgdh-/- mice. On each
side, the right panel is a higher magnification of the left panel, where arrows indicate lesions seen in brains of
l2hgdh-/- mice. Scale bars correspond to 300 μm or 50 μm as indicated.
doi:10.1371/journal.pone.0119540.g008
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abnormalities. Only a few pathological analyses have been reported. The seminal report by Lar-
naout et al. [38] confirmed the extensive demyelination and cavitation of the white matter,
mainly in the subcortical regions, spongiosis of the globus pallidus and the dentate nucleus
with marked cell loss, dilation of ventricles, moderate basal ganglia atrophy, and subcortical ne-
crotic foci in all cerebral lobes of a 30 year-old male with advanced disease. Another pathologi-
cal analysis of the brain of a 15 year-old patient with advanced disease confirmed symmetric
cystic cavities in the peripheral subcortical areas with intense spongiosis of the neuropil and of
the subcortical white matter, but no ventricular dilation, a better preserved cerebellar white
matter, and relatively few abnormalities of the basal nuclei and the dentate nuclei, although
spongiosis was also present in the brainstem and around the dentate nuclei [40]. In contrast,
Table 2. Psychomotor tests.
l2hgdh+/+ l2hgdh−/− p value
Food intake (g/g body weight) (n = 6) 0.256 ± 0.014 0.222 ± 0.020 0.185
Drink intake (ml/g body weight) (n = 6) 0.330 ± 0.045 0.237 ± 0.012 0.073
Rearing (count/48h) (n = 6) 1855 ± 810 4940 ± 927 0.031
Horizontal activity (AU) (n = 6) 7409 ± 1624 9344 ± 2752 0.558
Wire test (s) (n = 14) 85 ± 20 32 ± 9 0.024
Fore and hind limb grip (g/g body weight) (n = 14) 7.6 ± 0.4 7.2 ± 0.3 0.33
Open ﬁeld (n = 6)
Total distance moved (cm/20 min). 1st test 4117 ± 565 7207 ± 1161 0.032
Total distance moved (cm/20 min). 2nd test ¥ 2111 ± 263 5947 ± 1210 0.011
Decrease (%) 46.2 ± 6.4 20.1 ± 6.9 0.020
Y maze test (n = 6)
Alternance (%) 76.6 ± 4.6 55.0 ± 0.9 0.0009
Number of entry (count/5 min.) 17.2 ± 2.0 27.3 ± 2.8 0.014
Values are means ± SEM.
For all the tests, statistical analyses were performed using the Student t-test except for the open ﬁeld test
where statistical analysis was performed using a Two-way repeated measures ANOVA.
¥ The second test was done one month after the ﬁrst one. Note that the decrease of alternance observed in
l2hgdh−/− mice could not be explained by a decrease of activity, which was actually increased (number of
entry).
doi:10.1371/journal.pone.0119540.t002
Fig 9. Morris Water maze test. The average escape latencies, (i.e., the time required for l2hgdh+/+ and l2hgdh-/- mice to reach the platform) on the training
day and on the 3 consecutive trial days are shown in (A). The percentage of the time the mice spent in each quadrant of the platform arena on the 5th day of
testing (once the platform is removed) is shown in (B). The average distance (in cm) between the position of the mice during the latter test and the position
where the platform had been previously placed (Gallagher's coefficient) is shown in (C). Values are expressed as the means ± SEM (n = 9). Statistical
analyses were performed using a two-way repeated measures ANOVA (A), a one-way ANOVA (B) followed by a Newman-Keuls test, or a Student t-test (C).
*: p< 0.05.
doi:10.1371/journal.pone.0119540.g009
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the brain of the 1 month-old baby showed no spongiosis but severe atrophy, loss of neurons
and gliosis of the brainstem and the cerebellum, lesions strikingly different from those reported
in the other cases [2]. In dog, L-2-hydroxyglutaric aciduria also shows marked spongiform
changes, but surprisingly, these affect predominantly the gray matter of the cerebral cortex,
thalamus, brainstem and cerebellum [42]. In our mouse model, the extensive spongiosis of the
white matter is similar to human lesions (except the neonate patient) but no cavitation is
found. Spongiosis predominates in the pencils of Wilson and white matter fascicles surround-
ing the caudate putamen and basal ganglia but is also present in the subcortical white matter,
in the deep part of the cerebral cortex, in the brainstem and in the dentate nuclei. The rest of
the cerebellum and the hippocampus are minimally affected and no lesions are disclosed in the
spinal cord.
The absence of stainable material in the vacuolated cytoplasm, in particular by oil red O and
Sudan black on frozen sections, and the ultrastructural appearance of empty-looking dilated
cellular processes suggest a hydropic degeneration of the cytoplasm of oligodendrocytes ex-
tending into the myelin sheath of axons, and possibly also of astrocytes and of some neurons. It
should be noted that myelination was disrupted focally but well organized elsewhere, indicating
that it was most likely correctly performed during brain development before local disruptions
appeared during disease progression.
Spongiform encephalopathy is seen in different pathologies. In transmissible spongiform
encephalopathies due to prions, vacuoles are found in neurons and in their processes, sparing
the white matter and in particular the myelin bundles of the striatum [43]. In contrast,
l2hgdh-/- mice show marked vacuolar changes of the white matter and lamellar splitting of the
myelin sheath of axons. These lesions attributed to alterations in the oligodendrocytes are also
seen in a model of leukoencephalopathy resulting from disruption of the chloride channel ClC-
Fig 10. Sensitivity of l2hgdh-/- mice to the convulsant pentylenetetrazole. Six l2hgdh+/+ and 6 l2hgdh-/-
mice were placed in a plastic chamber (15 × 25 × 40 cm) and habituated for 10 min before intraperitoneal
injection of a subconvulsive dose (40 mg/kg) of pentylenetetrazole (PTZ, Sigma-Aldrich, St. Louis, MO, USA).
They were then video-tracked for 20 min and their behavior was classified and scored as follows: 0: normal;
1: immobilization; 2: facial, vibrissal and forelimb clonus (short myoclonic jerk); 3: myoclonic jerking
consisting of a whole body jerk with or without irregular, bilateral forelimb movements; 4: generalized clonic
seizures with kangaroo posture; 5: generalized tonic–clonic seizures with loss of posture tone; 6: death
(Watanabe et al. 2013). Statistical analyses were performed using the Student t-test (p = 0.0062).
doi:10.1371/journal.pone.0119540.g010
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2 [44] and in the Nur7 aspartoacylase-deficient mouse model of Canavan disease [43, 45].
However, distribution of the spongiform lesions varies among these three pathologies as well
as among species.
The marked vacuolar changes of the white matter found in the l2hgdh-/- mice are reminis-
cent of Canavan disease but marginally involve the hippocampus and the cerebellum and not
the spinal cord, in striking contrast to the spongy degeneration reported in the Nur7 aspartoa-
cylase-deficient mouse model of Canavan disease [45]. The spongy degeneration reported in
the Nur7mouse model is extensive in the cerebellum, the hippocampus and the gray matter of
the spinal cord in addition to the cerebral cortex, the subcortical white matter, the midbrain
and the pons but not in the optic nerves nor in the corpus callosum [45].
In the leukoencephalopathy model caused by disruption of the chloride channel ClC-2,
spongy degeneration predominates in the cerebellum, the corpus callosum, the internal cap-
sule, the brainstem and the white matter of the spinal cord but is not found in the optic nerves
[44]. ClC-2 appears to be expressed in oligodendrocytes and astrocytes, in addition to some
neurons of the hippocampus. ClC2-deficient (Clcn2-/-) mice display an early, severe retinal de-
generation that results in almost complete blindness from birth on and the selective absence of
vacuolation in their optic nerves suggests that the alterations of oligodendrocytes depend upon
neuronal activity. Interestingly, Clcn2-/- animals also lacked overt neurological deficits and re-
duced seizure thresholds despite widespread and extensive vacuolation of the white matter
[44]. This contrasts with the wide-based ataxic gait of young Nur7mice and the tremors and
seizures that appear in these mice with age. These observations indicate that the extent of spon-
giform degeneration is not directly linked to the neurological symptomatology.
Leukodystrophy is a common feature of metabolic diseases in which a dicarboxylic acid ac-
cumulates in brain (Canavan disease, glutaric aciduria type I, L-2-hydroxyglutaric aciduria).
This has been ascribed to poor permeability of the blood brain barrier to dicarboxylic acids
[46]. We propose that the mechanism of the toxicity may additionally involve irreversible
pumping of dicarboxylate into astrocytes and glial cells. Dicarboxylates, including L-2-hydro-
xyglutarate, are substrates for NaDC3 (SLC13A3), a sodium dependent transporter, which is
expressed in glial cells, though not in neurons [47]. The citrate transporter (NaDC2) shows no
affinity for L-2-hydroxyglutarate or other dicarboxylates [48, 49, 50]. It is therefore likely that
L-2-hydroxyglutarate accumulates mostly in glial cells (astrocytes and oligodendrocytes) and
therefore leads to major perturbations of these cells.
Correlation of neurological symptoms with pathological lesions in mice
L-2-hydroxyglutaric aciduria is consistently accompanied by major neurological problems,
such as progressive mental deficiency, severe cerebellar dysfunction, mild extrapyramidal and
pyramidal symptoms, progressive macrocephaly, and seizures [51, 52]. The l2hgdh-/- mice also
display neurological symptoms but the functional deficiencies appear limited compared to the
extensive spongiform degeneration of the white matter, suggesting that neurological symptoms
could be linked to other lesions, poorly or not visible morphologically. The increased locomo-
tor activity observed in the open field and in the Y maze tests might reflect the presence of le-
sions in basal ganglia. Associated to the lack of habituation observed in the open-field test, it
could also be due to hippocampal defects, as it is known that hippocampal lesions produce hy-
peractivity associated with a lack of habituation to a novel environment [53]. Moreover, hippo-
campal lesions are also associated with short-term and long-term learning deficits.
Accordingly, we observed a deficit of short-term memory (Y maze) and a deficit of long-term
memory (Morris water maze, long-term habituation to open field environment). Finally,
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l2hgdh-/- mice exhibited a more pronounced susceptibility to the convulsive drug pentylenete-
trazole, an effect also observed in animals presenting hippocampal lesions [54].
Conclusion
The concept of metabolite repair implies that abnormal metabolites need to be repaired be-
cause the abnormal products that may accumulate under some conditions may be damaging.
In this respect it is important to identify (1) the ‘culprit’ enzyme; (2) the metabolite repair en-
zyme; (3) the targets on which the abnormal metabolite acts. This paper provides new informa-
tion about all three questions and opens perspective for the elucidation of pathophysiological
mechanisms.
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